Cognition Therapeutics focuses on detecting Abeta proteins, a protein found in Alzheimer’s patients that leads to the degeneration in the brain. The company is also developing molecules to block the proteins’ negative results and either stop or reverse Alzheimer’s. The company says its discoveries could also treat other neurodegenerative diseases.

MentorTech Ventures, NewSpring Health Capital and the Pittsburgh Life Science Greenhouse will split $5 million in state loans they’ll use to invest in as many as 20 Pennsylvania-based medical companies.